Anxiety and depressive symptoms among home isolated patients with COVID-19: A cross-sectional study from Province One, Nepal

Khanal, Pratik; Paudel, Kiran; Mehata, Suresh; Thapa, Astha; Bhatta, Ramesh; Bhattarai, Hari Krishna

doi:10.1371/journal.pgph.0001046

Cited by 3 publications

(2 citation statements)

References 45 publications

(38 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We found that the female sex was significantly associated with an increased risk of probable depression, and similar findings have been reported in several other studies (15,21). Previous studies have reported an association between depression and having a family member diagnosed with COVID-19 but this was not observed among our participants (17,(22)(23)(24)(25).…”

Section: Discussionsupporting

confidence: 89%

See 1 more Smart Citation

Psychiatric morbidity among COVID-19 positive persons in Central Province, Sri Lanka: a cross-sectional study

Mirza¹,

Wijayatilake²,

Ratnayake³

et al. 2022

Sri Lanka J. Psyc.

View full text Add to dashboard Cite

IntroductionGlobally, the COVID-19 pandemic has been reported to have caused a significant psychosocial impact (1). Predominant psychological symptoms that have been reported to be associated with COVID-19 include, low mood, anxious preoccupation, irritability, lack of attention and concentration, insomnia and ideas of self-harm, while some studies have reported delirium, psychosis, and cognitive impairment (2). Studies from high-income countries (HIC) report that the pandemic is associated with increased levels of psychological morbidity, including depression, anxiety and post-traumatic stress disorder (PTSD) (3). There are only a few studies done in ConclusionsThe findings of this study indicate that a proportion of people diagnosed with acute COVID-19 infection experience psychological symptoms. This indicates the need for increased awareness about mental health issues associated with COVID-19 and the provision of appropriate psychological support for individuals at risk.

show abstract

Section: Discussionsupporting

confidence: 89%

“…We found a substantial prevalence of clinically significant depressive (18.6%) and anxiety (11.2%) symptoms. The prevalence of depressive symptoms was similar to that reported in studies among COVID-19 infected individuals in Nepal (26.3%) and China (14.2%), however, some other studies have reported higher values (2,(15)(16)(17)(18).…”

Section: Discussionsupporting

confidence: 87%

Psychiatric morbidity among COVID-19 positive persons in Central Province, Sri Lanka: a cross-sectional study

Mirza¹,

Wijayatilake²,

Ratnayake³

et al. 2022

Sri Lanka J. Psyc.

View full text Add to dashboard Cite

show abstract

Prevalence and factors associated with depression and anxiety among patients recovered from COVID-19: a cross-sectional study in a tertiary care hospital in Nepal

Rai,

Karmacharya,

Gautam

et al. 2024

bmjph

View full text Add to dashboard Cite

IntroductionCOVID-19 has immensely affected the mental health of all people with prominent effects among the COVID-19 survivors who underwent hospitalisation. The evidence of the long-term mental health implications among the recovered COVID-19 patients remains unknown in Nepal. The study aimed to determine the prevalence of depression and anxiety and the associated factors among COVID-19 recovered patients.MethodsAn analytical cross-sectional study was conducted from May to August 2021 among 269 COVID-19 recovered patients admitted to Dhulikhel Hospital during the first wave (July 2020 to January 2021), and second wave (April 2021 to July 2021) of the COVID-19 pandemic. Anxiety and depression of the participants were assessed using the Hospital Anxiety and Depression Scale. Multivariate logistic regression analysis was performed to determine the factors associated with anxiety and depression.ResultsThe prevalence of anxiety and depression were 38.66% (95% CI 32.99 to 44.65), and 30.48% (95% CI 25.24 to 36.28), respectively. Participants who received COVID-19 related information from the radio reported higher levels of anxiety and depression symptoms. Similarly, stigma, and being a health worker were significantly associated with a higher level of anxiety and depression symptoms, respectively. However, social support and long recovery duration were protective factors against anxiety and depression symptoms. Participants receiving a higher level of social support and having a recovery duration of 3–6 months, 7 months and more reported lower odds of anxiety and depression symptoms, respectively.ConclusionsThe greater prevalence of anxiety and depression symptoms among recovered COVID-19 patients highlights the need to design and implement appropriate mental health interventions. This could be done through psychosocial support and counselling services in health facilities, mental health service in emergency situation and post-discharge rehabilitation programmes.

show abstract

Cognitive impact on patients with COVID-19 infection

et al. 2023

View full text Add to dashboard Cite

Background SARS‐COV‐2 infection reframed medical knowledge in many aspects, yet there is still a lot to be discovered. Coronavirus disease 19 (COVID-19) can cause neuropsychiatric, psychological, and psychosocial impairments. Literature regarding the cognitive impact of COVID-19 is still limited. This study aims to evaluate cognitive function, anxiety, and depression among patients with coronavirus disease 19. Methods Sixty COVID-19 patients were recruited and sub-grouped according to the site of care into three groups, home isolation, ward, and RICU, and compared with 60 matched control participants. Entire clinical history, O2 saturation, mini-mental state examination (MMSE), Hamilton’s anxiety (HAM-A), and depression rating scales (HAM-D) were assessed. Results MMSE showed significantly lowest results for the ICU group, with a value of 21.65 ± 3.52. Anxiety levels were the highest for the ICU group, with a highly significant difference vs. the home isolation group (42.45 ± 4.85 vs. 27.05 ± 9.52; p< 0.001). Depression values assessed showed a highly significant difference in intergroup comparison (44.8 ± 6.64 vs. 28.7 ± 7.54 vs. 31.25 ± 8.89; p<0.001, for ICU vs. ward vs. home group, respectively). MMSE revealed a significant negative correlation with age and education level, anxiety level had significant negative correlations with severity of illness and male gender, and depression level had highly significant negative correlations with severity of illness and male gender. Conclusion Both cognitive and neuropsychiatric symptoms were affected in COVID-19 cases, especially in ICU-admitted patients. The impact of these disorders was significant in older age, lower oxygen saturation, and severe disease. Trial registration ClinicalTrials.gov. NCT05293561. Registered on March 24, 2022.

show abstract

Anxiety and depressive symptoms among home isolated patients with COVID-19: A cross-sectional study from Province One, Nepal

Cited by 3 publications

References 45 publications

Psychiatric morbidity among COVID-19 positive persons in Central Province, Sri Lanka: a cross-sectional study

Psychiatric morbidity among COVID-19 positive persons in Central Province, Sri Lanka: a cross-sectional study

Prevalence and factors associated with depression and anxiety among patients recovered from COVID-19: a cross-sectional study in a tertiary care hospital in Nepal

Cognitive impact on patients with COVID-19 infection

Contact Info

Product

Resources

About